Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England

Clinical Microbiology and Infection

Volumn 21, Issue 3, 2015, Pages 251.e1-251.e8

  Abernethy, J K ^a   Johnson, A P ^a   Guy, R ^a   Hinton, N ^a   Sheridan, E A ^a   Hope, R J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

All cause mortality; Escherichia coli bacteraemia; Multivariable analysis; Risk factors; Surveillance

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; ESCHERICHIA COLI INFECTION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SECONDARY HEALTH CARE; UNITED KINGDOM; UROGENITAL TRACT INFECTION; AGED; BACTEREMIA; CAUSE OF DEATH; CROSS INFECTION; DRUG EFFECTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEALTH SURVEY; INCIDENCE; ISOLATION AND PURIFICATION; LENGTH OF STAY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; ODDS RATIO; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ESCHERICHIA COLI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MORTALITY; ODDS RATIO; POPULATION SURVEILLANCE; RISK FACTORS; YOUNG ADULT;

EID: 84933564657     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.01.001     Document Type: Article

References (31)

1. Wilson J., Elgohari S., Livermore D.M., Cookson B., Johnson A., Lamagni T., et al. Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect 2010, 17(3):451-458.
2. Health Protection Agency Voluntary reporting of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland 2011, HPA website 2012 [cited 2014 Aug 6]; Available from: URL:. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/342872/S__aureus_bacteraemia_in_England_Wales_and_Northern_Ireland_2012_FINAL.pdf.
3. Lamagni T.L., Potz N., Powell D., Pebody R., Wilson J., Duckworth G. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005. JHosp Infect 2011, 77(1):16-20.
4. Wyllie D.H., Crook D.W., Peto T.E. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006, 333(7562):281-286.
5. Kang C.I., Song J.H., Chung D.R., Peck K.R., Ko K.S., Yeom J.S., et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010, 36(3):284-287.
6. Cordery R.J., Roberts C.H., Cooper S.J., Bellinghan G., Shetty N. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. JHosp Infect 2008, 68(2):108-115.
7. Apisarnthanarak A., Kiratisin P., Saifon P., Kitphati R., Dejsirilert S., Mundy L.M. Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Control Hosp Epidemiol 2008, 29(1):80-82.
8. Berger J., Diab-Elschahawi M., Blacky A., Pernicka E., Spertini V., Assadian O., et al. Amatched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance. Am J Infect Control 2010, 38(10):839-845.
9. Cheong H.S., Kang C.I., Kwon K.T., Heo S.T., Wi Y.M., Kim E.S., et al. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia. JAntimicrob Chemother 2007, 60(6):1355-1360.
10. Gudiol C., Calatayud L., Garcia-Vidal C., Lora-Tamayo J., Cisnal M., Duarte R., et al. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. JAntimicrob Chemother 2010, 65(2):333-341.
11. Lefort A., Panhard X., Clermont O., Woerther P.-L., Branger C., Mentré F., et al. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. JClin Microbiol 2011, 49(3):777-783.
12. Rodriguez-Bano J., Picon E., Gijon P., Hernández J.R., Cisneros J.M., Peña C., et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. JClin Microbiol 2010, 48(5):1726-1731.
13. Skjot-Rasmussen L., Ejrnaes K., Lundgren B., Hammerum A.M., Frimodt-Moller N. Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteraemia of urinary tract origin relate to sex and hospital- vs. community-acquired origin. Int J Med Microbiol 2012, 302(3):129-134.
14. Wu U.I., Wang J.L., Chen W.C., Chang S.C., Chen Y.C. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur J Clin Microbiol Infect Dis 2011, 30(1):33-39.
15. Kang C.I., Cheong H.S., Chung D.R., Peck K.R., Song J.H., Oh M.D., et al. Clinical features and outcome of community-onset bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2008, 27(1):85-88.
16. Schlackow I., Stoesser N., Walker A.S., Crook D.W., Peto T.E., Wyllie D.H. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011. JAntimicrob Chemother 2012, 67(6):1514-1524.
17. Skogberg K., Lyytikainen O., Ollgren J., Nuorti J.P., Ruutu P. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect 2012, 18(6):E170-E176.
18. Laupland K.B., Gregson D.B., Church D.L., Ross T., Pitout J.D. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect 2008, 14(11):1041-1047.
19. Williamson D.A., Lim A., Wiles S., Roberts S.A., Freeman J.T. Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011. BMC Infect Dis 2013, 13:385.
20. Office for National Statistics MR1000 Data Access Agreement 2014.
21. Office for National Statistics Mid 2011 Population Estimates: England and Wales; estimated resident population by single year of age and sex; based on the results of the 2011 Census 2012.
22. Reacher M.H., Shah A., Livermore D.M., Wale M.C., Graham C., Johnson A.P., et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000, 320(7229):213-216.
23. StataCorp College StationTX: StataCorp LP Stata Statistical Software: Release 12 2011.
24. Kennedy K.J., Roberts J.L., Collignon P.J. Escherichia coli bacteraemia in Canberra: incidence and clinical features. Med J Aust 2008, 188(4):209-213.
25. British Infection Association, Health Protection Agency. Diagnosis of UTI. Quick Reference Guide for Primary Care. HPA website 2013 [cited 2013 Nov 19]; Available from: URL: . http://www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1194947404720.
26. Royal Colleage of Nursing.Catheter Care RCN guidance for nurses 2012, Royal College of Nursing, London.
27. Alam M.F., Cohen D., Butler C., Dunstan F., Roberts Z., Hillier S., et al. The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. Int J Antimicrob Agents 2009, 33(3):255-257.
28. McNulty C.A.M., Verlander N.K., Turner K., Fry C. Point prevalence survey of urinary catheterisation in care homes and where they were inserted, 2012. JInfect Prev. 2014, 15(4):122-126.
29. Borg M.A., Suda D., Scicluna E. Time-series analysis of the impact of bed occupancy rates on the incidence of methicillin-resistant Staphylococcus aureus infection in overcrowded general wards. Infect Control Hosp Epidemiol 2008 Jun, 29(6):496-502.
30. Department of Health UK five year antimicrobial resistance strategy 2013 to 2018 2013, Department of Health, London.
31. Health Protection Agency. Escherichia coli bacteraemia in England, Wales and Northern Ireland, 2007-2011. HPA website 2013 [cited 2014 Aug 6]; Available from: URL: . http://webarchive.nationalarchives.gov.uk/20140714084352.